Background Gliomas are the most common and aggressive tumors of the central nervous
system. A robust and widely used blood-based biomarker for glioma has not yet been …

Background Numerous studies have demonstrated that the high-order features (HOFs) of
blood test data can be used to predict the prognosis of patients with different types of cancer …

Objective: The present study investigates a score based on baseline C-reactive protein
(CRP) and fibrinogen values (FC score) in 173 consecutive glioblastoma (GBM) patients …

Object The conception of individual patient-adjusted treatment strategies is constantly
emerging in the field of neuro-oncology. Systemic laboratory markers may allow insights into …

Background: Glioblastoma multiforme (GBM) is the most aggressive brain tumor affecting
adult patients, with an extremely reduced overall survival despite rapid diagnosis and …

Background: Metastatic melanoma disease is accompanied by highly systemic inflammatory
responses. The prognostic value of preoperative laboratory inflammation markers in brain …

Aim: To investigate the prognostic value of preoperative mean platelet volume (MPV),
MPV/lymphocyte ratio (MPVLR), MPV/platelet count ratio and plasma fibrinogen in patients …

Background Postoperative central diabetes insipidus (CDI) is commonly observed in
craniopharyngioma (CP) patients, and the inflammatory response plays an important role in …

Background Glioblastoma usually recurs locally and extracranial metastases are rare. Most
patients with extracranial metastases experience recurrence of the primary intracranial …

Background/Aim: Glioblastoma is the most malignant form of astrocytoma. The purpose of
this study was to analyze the genetic characteristics of primary and recurrent glioblastomas …